COP1 (Constitutive Photomorphogenic 1) antibodies are specialized immunological tools designed to detect and study the COP1 protein, an E3 ubiquitin ligase encoded by the RFWD2 gene in humans. COP1 regulates critical cellular processes, including protein degradation, cell cycle progression, and stress responses, by targeting substrates like FoxO1, p27, and c-Jun for ubiquitination . These antibodies enable researchers to investigate COP1's expression, localization, and functional roles in both physiological and pathological contexts, such as cancer metabolism and photomorphogenesis .
COP1 antibodies are widely used in molecular biology and clinical research. Key applications include:
Host Species: Rabbit
Reactivity: Human, mouse, rat
Dilution Range: 1:500–1:2000 (WB)
Host Species: Rabbit
Reactivities: Human, mouse, rat
Dilution Range: 1:50–1:500 (IHC), 1:500–1:1000 (WB)
Observed Molecular Weight: 90 kDa (vs. calculated 80 kDa due to post-translational modifications) .
Western Blot: Confirmed in human heart tissue and mouse models .
IHC: Strong staining in poorly differentiated gastric cancer tissues compared to normal tissues .
FoxO1 Degradation: COP1 promotes ubiquitination and proteasomal degradation of FoxO1, suppressing gluconeogenic genes like G6Pase and PEPCK in hepatoma cells .
Cell Cycle Regulation: COP1 interacts with p27 during G1 phase, accelerating its degradation to drive cell proliferation .
Cancer Metastasis: In gastric cancer, COP1 overexpression degrades CDH18, activating the PI3K/AKT pathway to enhance tumorigenesis .
Gastric Cancer: High COP1 expression correlates with advanced tumor infiltration (T stage) and poor prognosis .
TNBC and Colorectal Cancer: Cop1 knockout in murine models reduces tumor growth and enhances anti-PD-1 therapy efficacy .
COP1’s dual role as an oncoprotein (degrading tumor suppressors like p27) and tumor suppressor (targeting oncoproteins like c-Jun) highlights its potential as a cancer therapy target .
Question: What factors should I consider when selecting a COP1 antibody for my research?
Answer: When choosing a COP1 antibody, consider the species reactivity, application suitability (e.g., Western Blot, Immunoprecipitation, Immunohistochemistry), and the immunogen used. For example, Abcam's ab70890 is a rabbit polyclonal antibody suitable for human samples and immunoprecipitation , while ab56400 is a mouse monoclonal antibody suitable for multiple applications including flow cytometry and reacts with both human and mouse samples .
Question: How does COP1 function as an E3 ubiquitin ligase, and what are its implications in cellular processes?
Answer: COP1 acts as an E3 ubiquitin ligase by mediating the ubiquitination and subsequent proteasomal degradation of target proteins. It plays roles in regulating proteins like FoxO1, MTA1, and p53, impacting cell survival, metabolism, and cancer progression . Understanding these functions helps in interpreting data related to COP1's role in cellular processes.
Question: What are the optimal conditions for using COP1 antibodies in immunoprecipitation (IP) followed by Western Blot (WB)?
Answer: For IP, use a suitable antibody concentration (e.g., 3 µg/mL for ab70890) and ensure sufficient protein input (e.g., 1 mg for IP). For WB, use a lower antibody concentration (e.g., 1 µg/mL) and optimize detection conditions (e.g., chemiluminescence with a short exposure time) . Ensure proper controls, such as IgG controls, to validate specificity.
Question: How can I investigate the interactions between COP1 and its target proteins using co-immunoprecipitation assays?
Answer: To study COP1 interactions, perform co-immunoprecipitation assays using tagged proteins (e.g., HA-tagged FoxO1 and FLAG-tagged COP1). Pretreat cells with proteasome inhibitors (e.g., ALLN) to stabilize interactions. Analyze immunoprecipitates by Western Blot to detect co-precipitated proteins .
Question: How do I reconcile contradictory findings regarding COP1's role in different biological systems (e.g., plant vs. mammalian systems)?
Answer: Consider the context-specific functions of COP1. In plants, COP1 is involved in photomorphogenesis and pathogen resistance , while in mammals, it regulates cell survival and metabolism . Analyze experimental conditions, species-specific differences, and potential post-translational modifications that might influence COP1's activity.
Question: What strategies can I use to enhance the specificity of COP1 antibodies in complex biological samples?
Answer: To enhance specificity, use high-quality antibodies with well-characterized immunogens, optimize antibody concentrations, and include appropriate controls (e.g., IgG controls). Consider using peptide competition assays to validate specificity .
Question: How can I investigate COP1-mediated ubiquitination of target proteins?
Answer: To study COP1-mediated ubiquitination, co-transfect cells with tagged ubiquitin and COP1 expression vectors. Use immunoprecipitation followed by Western Blot to detect ubiquitinated proteins. Treat cells with proteasome inhibitors to stabilize ubiquitinated species .
Question: How can I integrate findings from COP1 studies across different species to understand its conserved functions?
Answer: Compare the structural and functional conservation of COP1 across species. Analyze the role of COP1 in similar biological processes (e.g., protein degradation pathways) and consider species-specific adaptations. Use bioinformatics tools to align sequences and predict functional motifs .
Question: What methods can I use to validate the interactions between COP1 and other proteins in vivo?
Answer: Validate COP1 interactions using co-immunoprecipitation assays in vivo. Employ techniques like GST pull-down assays to assess direct interactions. Additionally, use cellular fractionation to study the subcellular localization of interacting proteins .